Loxoprofen-induced interstitial pneumonia: a case report

Motoyasu Kato1,2, Shinichi Sasaki3,4, Yasuhito Sekimoto3,4

  • 1Department of Respiratory Medicine, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu, Chiba, 279-0021, Japan. mtkatou@juntendo.ac.jp.

Abstract

Insights

This case report details a rare instance of pneumonia caused by loxoprofen, a nonsteroidal anti-inflammatory drug. The patient experienced acute respiratory failure after re-administration of loxoprofen, highlighting a potential adverse drug reaction.

Area of Science:

  • Pharmacology
  • Pulmonology
  • Internal Medicine

Background:

  • Loxoprofen is a commonly prescribed nonsteroidal anti-inflammatory drug (NSAID) for various inflammatory conditions.
  • While NSAIDs have known side effects, drug-induced pneumonia is an infrequently reported adverse event.
  • This report addresses the absence of documented cases linking loxoprofen specifically to pneumonia.

Observation:

  • A 71-year-old woman developed worsening fever and dyspnea during loxoprofen treatment.
  • Following initial improvement with antibiotics, she experienced recurrent fever and acute respiratory failure after re-initiation of loxoprofen.
  • Chest CT revealed peribronchovascular consolidation, suggestive of an inflammatory pulmonary process.

Findings:

  • The patient was diagnosed with loxoprofen-induced pneumonia.
  • Symptoms and radiological findings resolved after discontinuation of loxoprofen and initiation of steroid therapy.
  • This case represents the first documented instance of pneumonia linked to loxoprofen use.

Implications:

  • This case highlights a potential, albeit rare, adverse effect of loxoprofen.
  • Clinicians should consider drug-induced pneumonia in patients presenting with respiratory symptoms during NSAID therapy.
  • Further investigation may be warranted to understand the mechanisms of NSAID-associated pulmonary toxicity.